Through gene expression analysis, the Alb-R26Met mice were shown to model a HCC patient subgroup corresponding to the so-called “proliferative-progenitor” subclass24, demonstrating the clinical relevance of this genetic system. This evidence concerns the gene ALB and hepatocellular carcinoma.